Gastrointestinal stromal tumors: Diagnosis, therapy and follow-up care in Austria

被引：0

作者：

Bareck, Evelyne ^{[1
]}

Ba-Ssalamah, Ahmed ^{[2
]}

Brodowicz, Thomas ^{[3
]}

Eisterer, Wolfgang ^{[4
]}

Haefner, Michael ^{[5
]}

Hoegenauer, Christoph ^{[6
]}

Kastner, Ulrike ^{[7
]}

Kuehr, Thomas ^{[8
]}

Laengle, Friedrich ^{[1
]}

Liegl-Atzwanger, Bernadette ^{[9
]}

Schoppmann, Sebastian F. ^{[10
]}

Widmann, Gerlig ^{[11
]}

Wrba, Fritz ^{[12
]}

Zacherl, Johannes ^{[13
]}

Ploner, Ferdinand ^{[14
]}

机构：

[1] Gen Hosp Vienna, Dept Surg, Vienna, Austria

[2] Med Univ Vienna, Clin Div Radiol, Vienna, Austria

[3] Med Univ Vienna, Gen Hosp, Dept Internal Med 1, Clin Div Oncol, Vienna, Austria

[4] Med Univ Innsbruck, Dept Internal Med 1, Innsbruck, Austria

[5] Hosp St Elisabeth, Dept Internal Med, Clin Div Gastroenterol, Vienna, Austria

[6] Med Univ Graz, Dept Internal Med, Clin Div Gastroenterol & Hepatol, Graz, Austria

[7] LabDia Labordiagnost GmbH, Vienna, Austria

[8] Hosp Wels, Dept Internal Med 4, Grieskirchen, Austria

[9] Med Univ Graz, Clin Div Pathol, Graz, Austria

[10] Med Univ Vienna, Gen Hosp, Dept Surg, Clin Div Gen Surg, Vienna, Austria

[11] Med Univ Innsbruck, Dept Radiol, Innsbruck, Austria

[12] Med Univ Vienna, Gen Hosp, Inst Clin Pathol, Vienna, Austria

[13] Hosp Herz Jesu, Dept Surg, Vienna, Austria

[14] Med Univ Graz, Dept Internal Med, Clin Div Oncol, Graz, Austria

来源：

WIENER MEDIZINISCHE WOCHENSCHRIFT | 2013年 / 163卷 / 5-6期

关键词：

GIST; Clinical recommendations; Treatment guidelines; Austria;

D O I：

10.1007/s10354-013-0187-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Optimal treatment for patients suffering from gastrointestinal stromal tumors (GIST) is based on an interdisciplinary treatment approach. Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine issued this manuscript on a consensual base within the context of currently available and published literature. This paper contains guidelines and recommendations for diagnosis, therapy, and follow-up of GIST patients in Austria.

引用

页码：137 / 152

页数：16

共 130 条

[11] NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic and genotypic characteristics
Andersson, J
Sihto, H
Meis-Kindblom, JM
Joensuu, H
Nupponen, N
Kindblom, LG
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1170 - 1176
[12] Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Andtbacka, Robert H. I.
Ng, Chaan S.
Scaife, Courtney L.
Cormier, Janice N.
Hunt, Kelly K.
Pisters, Peter W. T.
Pollock, Raphael E.
Benjamin, Robert S.
Burgess, Michael A.
Chen, Lei L.
Trent, Jonathan
Patel, Shreyaskumar R.
Raymond, Kevin
Feig, Barry W.
[J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) : 14 - 24
[13] Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas
Antonescu, Cristina R.
[J]. MODERN PATHOLOGY, 2008, 21 : S31 - S36
[14] Gastrointestinal Stromal Tumor: Role of Interventional Radiology in Diagnosis and Treatment
Avritscher, Rony
Gupta, Sanjay
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (01) : 129 - +
[15] Stereotactic Radiofrequency Ablation
Bale, Reto
Widmann, Gerlig
Haidu, Marion
[J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 34 (04) : 852 - 856
[16] Stereotaxy: Breaking the limits of current radiofrequency ablation techniques
Bale, Reto
Widmann, Gerlig
Stoffner, D. I. Rudolf
[J]. EUROPEAN JOURNAL OF RADIOLOGY, 2010, 75 (01) : 32 - 36
[17] High Density DNA Array Analysis Reveals Distinct Genomic Profiles in a Subset of Gastrointestinal Stromal Tumors
Belinsky, Martin G.
Skorobogatko, Yuliya V.
Rink, Lori
Pei, Jianming
Cai, Kathy Q.
Vanderveer, Lisa A.
Riddell, David
Merkel, Erin
Tarn, Chi
Eisenberg, Burton L.
von Mehren, Margaret
Testa, Joseph R.
Godwin, Andrew K.
[J]. GENES CHROMOSOMES & CANCER, 2009, 48 (10) : 886 - 896
[18] We should desist using RECIST, at least in GIST
Benjamin, Robert S.
Choi, Haesun
Macapinlac, Homer A.
Burgess, Michael A.
Patel, Shreyaskumar R.
Chen, Lei L.
Podoloff, Donald A.
Charnsangavej, Chuslip
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) : 1760 - 1764
[19] Blackstein ME, 2010 GASTR CANC S 20
[20] Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT
Blanke, Charles D.
Demetri, George D.
von Mehren, Margaret
Heinrich, Michael C.
Eisenberg, Burton
Fletcher, Jonathan A.
Corless, Christopher L.
Fletcher, Christopher D. M.
Roberts, Peter J.
Heinz, Daniela
Wehre, Elisabeth
Nikolova, Zariana
Joensuu, Heikki
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 620 - 625

← 1 2 3 4 5 6 7 8 9 10 →